🧫

iPSC-derived endothelial cell iron uptake with RLS CSF exposure

experiment Created: 2026-04-10 22:36:47 By: experiment_extractor Quality: 90% ✓ SciDEX ID: experiment-exp-bd558e54-410a-4a86-a620-3
🧫 Experiment Protocol Cell Biology
🧫 View Full Experiment Page →
Related Entities
TfR1
Metadata
experiment_typecell_biology
protocolHuman endothelial cells generated from iPSCs were exposed to CSF from RLS patients (n=14) or controls (n=15). Iron uptake and transport were measured, along with TfR1 protein expression, mRNA stabilit
expected_outcomesRLS CSF would alter iron handling in endothelial cells consistent with brain iron deficiency
success_criteriaSignificant differences in iron uptake/transport between RLS CSF and control CSF treated cells
sample_size29
statistical_methodsNone
p_valueNone
effect_sizeNone
extracted_at2026-04-10T15:36:47.730357
source_pmid41947413
_origin{'type': 'internal', 'url': None, 'tracked_at': '2026-04-10T22:36:47.732948'}
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (74)
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering100%
mentions📖TFR1 Gene90%
mentions📖TFR1 Gene80%
related📖TFR1 Gene72%
mentions📖CSF Biomarkers for Corticobasal Syndrome and Progressive Sup70%
mentions📖CSF Biomarker Comparison Across Neurodegenerative Diseases70%
mentions📖CSF Neurofilament Light Chain (NfL) in Neurodegeneration70%
mentions📖CSF O-GlcNAc — Target Engagement Biomarker for OGA Inhibitor70%
mentions📖csf-pta18170%
mentions📖CSF Synaptic Biomarker Panel for Neurodegenerative Diseases70%
mentions📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy70%
mentions📖CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 70%
mentions📖CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 70%
mentions📖CSF Cytokine Profiles as Parkinson's Disease Biomarkers70%
mentions📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy70%
mentions📖CSF Dynamics and Glymphatic Therapy in CBS/PSP70%
mentions📖CSF-1R Inhibitors70%
related📖CSF Biomarkers for Corticobasal Syndrome and Progressive Sup63%
related📖CSF Biomarker Comparison Across Neurodegenerative Diseases63%
related📖CSF Neurofilament Light Chain (NfL) in Neurodegeneration63%
related📖CSF O-GlcNAc — Target Engagement Biomarker for OGA Inhibitor63%
related📖csf-pta18163%
related📖CSF Synaptic Biomarker Panel for Neurodegenerative Diseases63%
related📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy63%
related📖CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 63%
related📖CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 63%
related📖CSF Cytokine Profiles as Parkinson's Disease Biomarkers63%
related📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy63%
related📖CSF Dynamics and Glymphatic Therapy in CBS/PSP63%
related📖CSF-1R Inhibitors63%
mentions📖Restless Legs Syndrome60%
mentions📖Blood-Brain Barrier60%
mentions📖Blood-Brain Barrier60%
mentions📖Endothelial Cells60%
mentions📖mechanisms60%
mentions📖researchers60%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering60%
related📖Restless Legs Syndrome60%
related📖Restless Legs Syndrome54%
related📖Blood-Brain Barrier54%
related📖Blood-Brain Barrier54%
related📖Endothelial Cells54%
related📖mechanisms54%
related📖researchers54%
mentions📖Ferroptotic Neurons50%
mentions📖Ferroptosis in Neurodegeneration50%
mentions📖Ferroptosis in Neurodegeneration50%
mentions📖Ferroptosis Pathway in Neurodegeneration50%
mentions📖Blood-Based Biomarkers for Neurodegeneration44%
mentions📖Blood Biomarkers for Atypical Parkinsonism - Testing Guide44%
mentions📖Blood Microbial Signatures in Parkinson's Disease44%
mentions📖Blood p-Tau181 and p-Tau217 Elevated in Systemic Amyloidoses44%
mentions📖Blood p-Tau217 as a Clock for Alzheimer's Disease Onset44%
mentions📖blood-brain-barrier-endothelial-cells44%
mentions📖Blood-Brain Barrier Transport Cells44%
mentions📖Blood Flow Restriction for Optimizing Balance in Parkinson&#44%
mentions📖blood-flow-restriction-pd-balance-nct0650880144%
mentions📖RMT-TfR1 Bispecific Antibody Shuttle for CNS Delivery44%
mentions📖Blood-Brain Barrier Penetration Technologies Investment Land44%
mentions📖Blood-Brain Barrier Breakdown in Alzheimer's Disease44%
mentions📖Blood-Brain Barrier Breakdown as Primary Disease Driver44%
mentions📖Blood-Brain Barrier Dysfunction in 4R-Tauopathies44%
mentions📖Blood-Brain Barrier Dysfunction Pathway44%
mentions📖Blood-Brain Barrier Dysfunction in Vascular Cognitive Impair44%
mentions📖Blood-Based Biomarkers for Neurodegeneration44%
mentions📖Blood-Brain Barrier in 4R-Tauopathies44%
mentions📖Blood-Brain Barrier Biology and Crossing Strategies44%
mentions📖Blood-Brain Barrier Breakdown in Neurodegeneration44%
mentions📖Blood-Brain Barrier Dysfunction in Neurodegeneration44%
mentions📖Blood p-Tau217 as a Clock for Alzheimer's Disease Onset44%
mentions📖Ferroptosis in Alzheimer's Disease44%
mentions📖Iron Dysregulation in Neurodegeneration44%
mentions📖Blood-Brain Barrier Crossing Technologies for Neurodegenerat44%
mentions📖Lundbeck/Genentech Bispecific Brain Shuttle Antibodies44%

💬 Discussion